Company / R&D Expense
CorMedix Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$19.3M
FY2025
5-year range
$3.9M / $19.3M
FY2021-FY2025
Trend
+390.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense changed +390% YoY in FY2025, a notable deviation from the 9-year average annual change of +158%.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of +11.8%.
Improved from $13M to $19M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +13.8%
- 5-Year CAGR
- +11.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.8%, indicating consistent growth.
- In FY2025, r&d expense increased 390.4% year-over-year.
- Peak r&d expense was recorded in FY2018.
- Lowest r&d expense in the period was in FY2016.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.3M | +390.4% |
| FY2024 | $3.9M | -70.0% |
| FY2023 | $13.2M | +0.2% |
| FY2022 | $13.1M | -1.8% |
| FY2021 | $13.4M | +21.0% |
| FY2020 | $11.1M | -41.3% |
| FY2019 | $18.8M | -23.1% |
| FY2018 | $24.5M | +55.6% |
| FY2017 | $15.7M | +1093.2% |
| FY2016 | $1.3M | -79.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026